Health IT Generated PROs to Improve Outcomes in Cirrhosis

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
Cirrhosis affects more than 6 million US patients and is a major burden on patients, caregivers and the healthcare system. Patients with cirrhosis are prone to clinical and psycho‐social issues that may predict hospitalization, re‐hospitalizations and death. Important patient‐reported outcomes (PRO) such as impaired daily functioning, sleep, cognition and pain are widely prevalent in patients with cirrhosis. These changes can independently impact hospitalizations, re‐hospitalizations and death in cirrhotic patients. The investigators have studied the impact of these PRO using traditional and computerized scales such as PROMIS (Patient‐reported outcomes measurement information system). With the increasing spread of health‐related electronic devices, the relevance of health IT in the management of chronic diseases such as cirrhosis is paramount. The team has already developed and used several health IT advances to educate patients and their caregivers in inpatient and outpatient settings. These tools are Patient Buddy to define patients regarding factor preventing readmission, and EncephalApp Stroop to detect cognitive dysfunction in cirrhosis. As part of a funded AHRQ R21, PatientBuddy, which has undergone multiple refinements in response to feedback from patients, caregivers and administering staff, is being used by the study team to prevent readmissions to Virginia Commonwealth University Medical Center (VCU). However the evaluation of these tools in a multi‐center study that adapts to the status of the patients and their caregivers is an important step towards improvement in cirrhosis‐related outcomes. In addition, PROs that are elicited and monitored when the patients are outside the hospital will advance the field by making them integral parts of clinical management.
Epistemonikos ID: 63ef707a7a9968c607b9cb4d94e014d9a0ad15bb
First added on: May 21, 2024